Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation

BACKGROUND: The risk of local recurrence after high-intensity focused ultrasound (HIFU) is relatively high, resulting in poor prognosis of malignant tumors. The combination of HIFU with traditional chemotherapy continues to have an unsatisfactory outcome because of off-site drug uptake. RESULTS: Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jian, Hao, Junnian, Chen, Yini, Liu, Hairong, Wu, Jianrong, Hu, Bing, Wang, Yan, Zheng, Yuanyi, Cai, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555249/
https://www.ncbi.nlm.nih.gov/pubmed/34715854
http://dx.doi.org/10.1186/s12951-021-01087-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555249/
https://www.ncbi.nlm.nih.gov/pubmed/34715854
http://dx.doi.org/10.1186/s12951-021-01087-w

Ejemplares similares